Cargando…
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Genetic variations along with epigenetic modifications of DNA are involved in colorectal cancer (CRC) development and progression. CRC is the fourth leading cause of cancer-related deaths worldwide. Initiation and progression of CRC is the cumulation of a variety of genetic and epigenetic changes in...
Autores principales: | Patnaik, Srinivas, Anupriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563763/ https://www.ncbi.nlm.nih.gov/pubmed/31244652 http://dx.doi.org/10.3389/fphar.2019.00588 |
Ejemplares similares
-
Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022) -
Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria
por: Yang, Bingqing, et al.
Publicado: (2021) -
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022) -
Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023) -
Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)